TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/16/24 17:45 | 4/12/24 | RCKT | Rocket Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Southwell David P | NJ | D | M.dm | 433 | 4.34 | 0 | 100 | 657 | 115 | D | |||||||||||||||
4/16/24 17:45 | 4/12/24 | RCKT | Rocket Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Southwell David P | NJ | D | S.dm | -1,946 | 24.32 | 0 | -80 | -41 | 115 | D | |||||||||||||||
5/20/22 16:15 | 5/18/22 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Southwell David P | MA | DO | CEO | P | 90 | 3.59 | 0 | 25 | 17 | 172 | D | ||||||||||||||
12/27/21 16:30 | 12/23/21 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Southwell David P | MA | DO | CEO | M.d | 96 | 1.97 | 0 | 49 | 50 | 147 | D | ||||||||||||||
9/9/21 16:43 | 9/8/21 | TCRX | Tscan Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Southwell David P | MA | DO | CEO | P | 96 | 8.73 | 0 | 11 | 13 | 98 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |